319 Million Shares Down.

SpaceX stock opened down more than 3% Thursday morning as 319 million shares held by early employees and investors became eligible to trade. By midday, SPCX had fallen nearly 5%, trading below its $135 IPO price. The surface story writes itself: more shares, lower price.

The surface story is also the least important part of what is happening to SPCX right now.

The 319 million shares unlocking today are the second tranche in a staggered schedule that runs through December 8, 2026, and on into June 2027. Understanding how that schedule compounds, not just today’s number but the full supply stack, is the analytical work most headlines are skipping. Traders who map the entire calendar before November will be better positioned than those reacting to each individual date.

The Supply Calendar Nobody Is Reading Closely Enough

Start with what has already happened. SpaceX priced its IPO at $135 per share in June, raising approximately $75 billion in what became the largest IPO in recorded history. The initial public float was roughly 4% to 5% of total shares outstanding. On August 6, the first post-IPO unlock released up to 912 million shares, more than doubling the float. The market absorbed that tranche cleanly: the stock rose about 6% that day.

Today’s 319 million shares are the day-70 time tranche. They represent roughly 2% to 3% of total shares outstanding and, at recent prices, carry a market value in the tens of billions of dollars. The event is real but context matters: this tranche is about 35% the size of the August 6 unlock that the market swallowed without flinching.

What comes next is heavier. A 1.3 billion-share tranche is set to unlock two trading days after SpaceX reports Q3 2026 results, followed by the main 180-day expiry on December 8, 2026. Elon Musk’s 6.4 billion shares remain locked until June 12, 2027 under a separate lockup with no early-release provisions disclosed in the widely reported schedule. Between today’s unlock and Musk’s expiry, the market must absorb supply that dwarfs anything it has processed so far.

There is also a separate dilution event that sits outside the lockup schedule entirely. On August 14, SpaceX completed its $60 billion all-stock acquisition of Anysphere, the company behind AI coding platform Cursor. The deal converted Cursor’s outstanding shares into 389,289,254 SpaceX Class A shares, with additional unvested RSUs and options assumed into the SpaceX equity structure. Those shares entered the capital table through a private issuance, meaning resale registration timing will be determined separately from the standard lockup schedule. The Cursor supply is not today’s problem. It is a 2027 overhang that the market has not yet fully mapped.

Where the Business Actually Stands

The supply calendar lands on top of a valuation debate that was already unresolved. SpaceX trades near $1.8 trillion to $1.9 trillion in market cap at recent levels, which implies a price-to-sales multiple around 47 times if you apply consensus-style 2026 revenue estimates near $39 billion. That is not a value stock multiple. It is a bet that the business transforms rapidly enough to compress the multiple before the multiple compresses the stock.

The Q2 results, reported August 4, provided real support for the bull case. Revenue came in at $7.814 billion, up 92% year-over-year, and adjusted EBITDA reached $3.5 billion, up 191% year-over-year. The company ended the quarter with about $100 billion in cash and marketable securities, reflecting both IPO proceeds and a $25 billion investment-grade bond issuance. Connectivity, the Starlink segment, generated $4.29 billion in revenue, up 66% year-over-year, with operating income of about $1.66 billion, and Starlink subscribers reached 12 million at quarter end, doubling from a year earlier.

The problem embedded in those numbers is capital intensity. Capital expenditure is running at levels that are difficult to reconcile with near-term free cash flow, and the company’s own disclosures and coverage have repeatedly highlighted elevated AI-related spending. Management guided to a $100 billion annualized revenue run rate by year-end, predicated on a $47.5 billion backlog and contributions from the Cursor integration beginning in Q4. That target, even if achieved, would still leave the stock at an elevated multiple versus any comparable at scale.

Who Owns It and What Their Cost Basis Tells You

Fresh 13F filings released this week revealed that roughly 1,700 institutions have built positions in SPCX since the June IPO. The concentration, however, is extraordinary. Alphabet leads at 551.2 million shares and Valor Management disclosed 503.4 million shares. Fidelity disclosed 302.6 million, venture firm Gigafund has 171.8 million, Saudi Arabia’s Public Investment Fund holds 154.1 million, and Nvidia’s 13F shows 122.8 million shares. Peter Thiel’s Founders Fund-related entities are among the large holders disclosed in the filings.

That concentration matters for supply dynamics. Alphabet’s position was built on a widely reported $900 million 2015 investment that is now worth roughly $94 billion at recent prices. Cost basis matters enormously when evaluating the probability of selling. Holders who entered at far lower private-market valuations have a very different incentive set than IPO buyers. The question is not whether they want to sell eventually. Most will. The question is whether today’s price justifies acceleration versus waiting for Musk’s lock to expire in June 2027, which would provide a clearer directional signal about the company’s largest single supply overhang.

What the Chart Is Telling You Right Now

The chart tells a clear story about where SPCX stands as today’s unlock processes. The stock reached an all-time high of $225.64 shortly after the IPO, then hit an intraday low of $104.83 on August 3, and staged a sharp recovery into mid-August. The Fibonacci structure drawn from the $225.64 high to the $104.83 low places the 38.2% retracement near $151 and the 61.8% retracement near $179. Today’s selloff is testing the midpoint zone around the high-$130s to low-$140s.

The IPO price at $135 functions as psychological support and is being tested. Average analyst price target across recent coverage sits around the low-$200s, with a high of $800 and a low in the low-$100s. Morgan Stanley maintains a $300 base case and a $600 bull scenario. The analyst range for SPCX is unusually wide, which itself reflects genuine uncertainty about the multiple an AI-infrastructure-plus-launch-plus-connectivity conglomerate deserves.

Volume is the data point to monitor alongside price today. The 319 million unlocked today represent multiple days’ worth of typical activity. If the day closes with volume materially below the unlocked share count, it suggests holders are choosing not to sell at current levels, which would be structurally constructive. If volume accelerates toward or above the unlock size, price discovery becomes the dominant mechanism into the close.

Three Paths From Here

Bull Case: $165 to $179 by Year-End

The conditions required for SPCX to trade to $165 to $179 before December 8 are specific. The stock must hold the low-$130s through today’s session and reclaim the mid-$140s before the September tranches arrive. The $100 billion annualized revenue run rate guidance must receive independent validation in Q3 earnings, ideally with the Cursor contribution showing up in contracted backlog growth above $55 billion. The 1.3 billion-share November tranche must be absorbed without a structural break below the mid-$120s, the approximate level where institutional support from cost-basis buyers at pre-IPO rounds would begin to look less compelling as a floor. Morgan Stanley’s $300 base case requires roughly 120% upside from the mid-$130s, which demands 2027 revenue acceleration and multiple expansion rather than compression. That is achievable if AI cloud contract ramps materialize on management’s timeline, but it is not the base case for positioning today.

Base Case: Range-Bound Between $125 and $155 Through December

The most probable path through the remainder of 2026 is a stock that oscillates between the $125 technical floor and the $150 to $155 resistance zone, with each lockup unlock creating temporary pressure that longer-duration holders absorb selectively. The November Q3 tranche is the event that most threatens this range: 1.3 billion shares arriving alongside earnings introduces both supply shock and fundamental catalyst simultaneously. If earnings match or exceed Q2’s beat rate, the tranche becomes a buying opportunity. If earnings disappoint, the supply and the negative sentiment compound. In the base case, valuation multiple compression offsets operational growth, holding the stock near current levels through year-end.

Bear Case: Retest of $104 to $110

The bear case does not require a business failure. It requires a combination of events: the November tranche generates sustained net selling pressure, the AI segment’s operating losses remain large, and Cursor-related resale registration proceeds faster than the market expects, creating a fourth simultaneous supply source alongside the standard lockup calendar. A December that combines the full 180-day expiry with additional scheduled releases would put hundreds of millions of additional shares into the market in a compressed window. The $104.83 intraday low from August 3 is the natural retest level in that scenario, and a failure to hold it would open the mid-$80s.

How to Trade Around What’s Coming

Three tactical considerations frame how disciplined traders should approach SPCX from here.

Float math over price action on unlock days. The reflexive move on lockup dates has been wrong before. The August 6 unlock produced a gain, not a collapse. The correct variable to monitor is not whether the price drops on unlock day but whether volume indicates meaningful distribution. If it does not, the structural picture remains constructive for medium-term holders. If it does, it signals that meaningful pre-IPO holders are choosing to exit, which changes the supply calculus for the November and December events.

The November Q3 earnings tranche is the real decision point. The 1.3 billion shares set to unlock two trading days after Q3 results represent the largest single supply event remaining in 2026. Traders with positions initiated at current prices should define their November risk tolerance now rather than during the event. Key levels to monitor: the mid-$120s as the first structural support zone, the low-$110s as broader support, and $104.83 as the key post-IPO downside reference point for risk sizing.

Volatility positioning has a logic before each tranche. SPCX options markets are pricing significant event volatility around each unlock date. Traders who prefer defined-risk structures may find that positioned volatility around the September tranches offers better risk-reward than directional exposure to what remains an unpredictable supply absorption process. Implied volatility tends to compress after unlocks that are absorbed cleanly, which creates a mechanical pattern that structured traders can exploit without taking a directional view on a stock whose analyst range spans from the low-$100s to $800.

One number sits above the rest of this analysis: 6.4 billion. That is Musk’s share count, locked until June 12, 2027. Every tranche between now and then is secondary supply from employees, early investors, and deal counterparties. Musk’s block is primary supply in scale, and June 2027 is when the real supply test arrives. Everything between now and then is preparation for that event, not a resolution of it.

The Work That Matters Gets Done Before November

Today’s decline on 319 million unlocked shares is noise relative to the structural supply calendar SPCX carries through the next twelve months. The business is real: $7.814 billion in quarterly revenue, 92% year-over-year growth, 12 million Starlink subscribers, and a $47.5 billion backlog are not fabricated numbers. The valuation is also real: a price-to-sales multiple around the high-40s to low-50s is a multiple that requires years of compounding execution to justify. The lockup calendar does not care about either of those facts on its own schedule. It releases shares based on time and earnings triggers, and the November tranche is the one that demands preparation now, not a reaction when it arrives.

Disciplined traders map supply before it becomes headline risk. The calendar above is the map. The levels are known. The scenarios are defined. What separates prepared positioning from reactive positioning is simply whether the work is done before November, or after.

For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.